Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 6:15 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2473–2496 of 2,761 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Male Osteoporosis
Interventions: Teriparatide or human parathyroid hormone (PTH) 1-34, Cinacalcet, placebo tablet, Calcium citrate tablet, Vitamin D3; Drug · Dietary Supplement
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years to 85 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
Interventions: Cord Blood Units, Total Body Irradiation, Cyclophosphamide, Fludarabine, Clofarabine, Busulfan, Thiotepa, Tacrolimus, Mycophenolate Mofetil, Cyclosporine; Biological · Radiation · Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Up to 26 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Neoplasm, Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Stage IV Breast Cancer
Interventions: G1T48, Palbociclib; Drug
Lead sponsor: G1 Therapeutics, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 6
States / cities: Beverly Hills, California • Stanford, California • Chicago, Illinois + 3 more

Conditions: Advanced Solid Tumors
Interventions: Debio 0123; Drug
Lead sponsor: Debiopharm International SA; Industry
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 4
States / cities: Grand Rapids, Michigan • New York, New York • San Antonio, Texas + 1 more

Conditions: Concussion, Brain, Mild Traumatic Brain Injury
Interventions: EyeBOX Lens (EBLens); Device
Lead sponsor: Oculogica, Inc.; Industry
Eligibility: 17 Years to 35 Years
Enrollment: 1,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: West Point, New York

Conditions: Hyperglycemia
Interventions: High-Intensity Functional Training, Aerobic and Resistance Training; Other
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Blood Pressure Monitoring, Hypertension (HTN), Pregnancy
Interventions: Enhanced Care Group, Remote Blood Pressure Monitoring alone; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older · Female only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Type 2 Diabetes
Interventions: Remotely delivered Mindfulness-Based Diabetes Education, Standard Diabetes Self Management Education; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Parkinson Disease, Weight-Lifting Exercise Program
Interventions: Periodized training with motor practice, Simple Periodized Training; Other
Lead sponsor: University of Miami; Other
Eligibility: 40 Years to 89 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Coral Gables, Florida

Conditions: Schizophrenia, Schizo Affective Disorder
Interventions: rTMS; Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 45 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Indianapolis, Indiana

Conditions: Postexercise Hypotension
Interventions: Continuous Exercise, Aerobic Interval Exercise; Other
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Phoenix, Arizona

Conditions: 160 Participants Aged 18-35 Years and Obese (BMI ≥30) Open to Men and Women of All Ethnicity
Interventions: Glycemic Load, Resistance Training; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 35 Years
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Systemic Lupus Erythematosus
Interventions: Anifrolumab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: Female only
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Dietary Carcinogenesis
Interventions: ACCS100, Placebo; Drug
Lead sponsor: Texas Enterosorbents Incorporated; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 234 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Overweight and Obesity
Interventions: Intervention Targeting Stress and Emotion Regulation, Intervention Targeting Motivation and Self-efficacy for Weight Management, Intervention for Normalization of Eating, Intervention Targeting Physical Activity and Sleep; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Opioid-use Disorder
Interventions: Oxy(Gly)4-sKLH vaccine - Low Dose, Oxy(Gly)4-sKLH vaccine - High Dose, Placebo Oxy(Gly)4-sKLH vaccine; Biological
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 59 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2027
U.S. locations: 2
States / cities: Eatontown, New Jersey • New York, New York

Conditions: Metabolic Syndrome
Interventions: Metformin, Placebo, Low Intensity Exercise, High Intensity Exercise; Drug · Behavioral
Lead sponsor: Rutgers University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 91 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Lymphoma, Lymphoma, B-Cell
Interventions: Rituximab, Etoposide, Prednisone, Vincristine, Cyclophosphamide, Doxorubicin, CAPP-seq; Drug · Device
Lead sponsor: Jennifer Amengual; Other
Eligibility: 15 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Stanford, California • New York, New York

Conditions: Hypertension
Interventions: Exercise Program, Combined Exercise and Diet Program; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 25 Years to 60 Years
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: San Diego, California

Conditions: Focus is on Healthy Subjects
Interventions: Reusable, Transparent, and Reconfigurable N95-Equivalent Respirator Masks: Design, Fabrication, and Clinical Trials for Enhanced Adoption; Device
Lead sponsor: SEEUS95 Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Weight Gain, Resistance Training, Overeating
Interventions: High-calorie mass gainer supplement, Resistance Training; Dietary Supplement · Other
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Eosinophilic Esophagitis
Interventions: swallowed sponge device; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pediatric Abusive Head Trauma
Interventions: Application of a validated Clinical Decision Rule (CDR) as an AHT screening tool; Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: Up to 3 Years
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 8
States / cities: Hartford, Connecticut • Wichita, Kansas • Kansas City, Missouri + 5 more

Conditions: Healthy
Interventions: Histidine; Dietary Supplement
Lead sponsor: Cornell University; Other
Eligibility: 21 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Ithaca, New York

Search by objective public record fields.

Novel Combination Therapy for Osteoporosis in Men

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer

A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors

A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward Settings

CrossFit Exercise to Improve Glucose Control for Overweight and Obese Adults

Community Health Worker Coaching to Reduce Cardiovascular Risk Among Women After a Hypertensive Disorder of Pregnancy

Remotely Delivered Mindfulness-Based Diabetes Education

Daily Undulating Periodization Methods With Parkinson's Disease

Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP)

Continuous vs Aerobic Postexercise Hypotension

Glycemic Load & Resistance Training on Endothelial Function & Insulin Sensitivity

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100"

Control Systems Engineering for Weight Loss Maintenance

Clinical Trials of Multivalent Opioid Vaccine Components

Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Effect of Exercise and Diet on Inflammation in Hypertensive Individuals

Reusable, Transparent, and Reconfigurable N95-equivalent Respirator Masks: Design, Fabrication, and Trials for Enhanced Adoption

Body Composition Changes During Overfeeding Plus Resistance Training

Sponge and Eosinophil Peroxidase (EPO) Staining

The CDR Implementation Trial

Safety of Graded-Dose of Histidine in Humans